Therapeutic Asset Ratings

4,493 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
cc-5013 Recurrent Adult T-cell Leukemia/Lymphoma	National Cancer Institute (NCI)	P2	BBB (74)
DEXAMETHASONE Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma	National Cancer Institute (NCI)	P2	BBB (74)
VINCRISTINE SULFATE AIDS-related Peripheral/Systemic Lymphoma	National Cancer Institute (NCI)	P2	BBB (74)
CIS-DIAMMINEDICHLOROPLATINUM II Neuroendocrine Neoplasm	National Cancer Institute (NCI)	P4	BBB (73)
Cyclophosphamide Non-Hodgkin's Lymphoma	National Cancer Institute (NCI)	P4	BBB (73)
EXEMESTANE HER2/Neu Negative	National Cancer Institute (NCI)	P4	BBB (73)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Non-Hodgkin's Lymphoma	National Cancer Institute (NCI)	P4	BBB (73)
Inno-206 Gamma Delta Hepatosplenic T-Cell Lymphoma	National Cancer Institute (NCI)	P4	BBB (73)
Inno-206 Hepatosplenic T-Cell Lymphoma	National Cancer Institute (NCI)	P4	BBB (73)
Oxodotreotide Gastroenteropancreatic Neuroendocrine Tumor	National Cancer Institute (NCI)	P4	BBB (73)
PEGASPARGASE Childhood T Acute Lymphoblastic Leukemia	National Cancer Institute (NCI)	P3	BBB (73)
Cediranib Adult Anaplastic Astrocytoma	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Adult Anaplastic Oligodendroglioma	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Adult Mixed Glioma	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Brain and Central Nervous System Tumors	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Recurrent Childhood Rhabdomyosarcoma	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Recurrent Colon Cancer	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Recurrent Neuroblastoma	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Recurrent Osteosarcoma	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Recurrent Small Cell Lung Carcinoma	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Stage IVA Rectal Cancer	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Stage IV Prostate Cancer	National Cancer Institute (NCI)	P2	BBB (73)
Cediranib Stage IV Rectal Cancer	National Cancer Institute (NCI)	P2	BBB (73)
Fludarabine Hepatosplenic T-cell Lymphoma	National Cancer Institute (NCI)	P2	BBB (73)

Showing 26 to 50 of 4,493 assets

PreviousPage 2 of 180Next